iPierian ipierian.com


Public list: Smart Money VCs (6328) Pharma Startups (4743) Google In Healthcare (60) Neuroscience Startups (947)

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Alzheimer's disease and other tauopathies (e.g. progressive supranuclear palsy, frontotemporal dementia). The company's lead antibody, IPN007, represents a new approach to Alzheimer's by targeting a novel form of secreted Tau protein that is differentially regulated in Alzheimer's disease patients, to...Show all

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Alzheimer's disease and other tauopathies (e.g. prog...Show all

Company (Acquired)

Phone: 650-872-4700

Fax:

951 Gateway Boulevard

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
iPierian $95.7M Apr 29, 2014
See all 92 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related iPierian Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Google VenturesCorporate VentureMountain View, California, United StatesSeries C, Series B - II, Series B
Biogen Idec New VenturesCorporate VentureCambridge, Massachusetts, United StatesSeries C, Series B - II
FinTech Global CapitalVenture CapitalJapanSeries C, Series B - II, Series B, Series A - II
ATEL VenturesDebt & Specialty FinanceSan Francisco, California, United StatesSeries C, Series B - II, Series B
California Institute of Regenerative MedicineGovernmentSan Francisco, California, United StatesGrant - II
See all 12 investors

Competitors

Company Status Description Investors
See all 92 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of treating a tauopathy Aug 11, 2016 Oct 03, 2017 Patent
Methods of treating a tauopathy Aug 15, 2013 Feb 14, 2017 Patent
Methods of treating a tauopathy May 06, 2015 Sep 20, 2016 Patent
Methods of treating a tauopathy Sep 09, 2014 Jun 09, 2015 Patent
Methods of treating a tauopathy May 19, 2014 Mar 17, 2015 Patent
See all 14 patents